Co-Diagnostics annual meeting fails quorum twice; adjourned again to Sept 30, 2026

Co-Diagnostics, Inc.

Annual Meeting held September 3, 2026 did not achieve a quorum and could not transact business; meeting adjourned.
Adjourned meeting on September 24, 2026 also failed to reach quorum, so no shareholder votes were taken.
Meeting adjourned again to September 30, 2026 at 9:00 a.m. Mountain Time at company offices, 2401 S. Foothill Dr, Ste. D, Salt Lake City, Utah.
Valid proxies submitted earlier remain valid for the reconvened meeting unless properly changed or revoked; items are per the July 21, 2026 definitive proxy.
CEO Dwight Egan signed the report dated September 24, 2026; no voting results for any proposal were disclosed.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.